Tate & Lyle Acquires CP KELCO for $1.8 Billion to Strengthen Plant-Based Portfolio
Tate & Lyle, a British sweetener manufacturer, announced the acquisition of US-based CP Kelco for $1.8 billion. This strategic move is intended to boost Tate & Lyle's specialty ingredients business to meet the growing demand for plant-based products.
The acquisition transaction includes $1.15 billion in cash and the issuance of 75 million new Tate & Lyle shares to CP Kelco's parent company, JM Huber Corporation. The transaction will make JM Huber the largest shareholder of Tate with a 16% stake and the right to appoint two non-executive directors to Tate's board of directors. CP Kelco, known for its pectin, specialty gum and other natural ingredients, has recently faced declining sales and margin pressures, sparking investor concerns. The proposed transaction is expected to generate at least $50 million in cost benefits by the end of the second fiscal year after completion.
The acquisition is in line with Tate & Lyle's strategy to meet growing consumer demand for sustainable plant-based products and fewer artificial additives. Chief Executive Officer Nick Hampton stressed that the deal would help the company meet the growing market for sustainable ingredients.Despite the strategic fit, Tate & Lyle’s shares fell more than 8%, reflecting investor concerns about CP Kelco’s recent performance.
2026-09-12
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
GACL Approves Additional Hydrochloric Acid Unit at Dahej
-
Croda’s First-Half Profit Outpaces Sales as Beauty Actives Grow 19%
-
Nylon Giant to Close Another European Plant, Cutting 140 Jobs
-
BASF Battles Market Turmoil as Profits Slide
-
Profit Soars While Sales Dip: Syngenta Group Defies Headwinds with 28% EBITDA Surge in Q3 2025
-
Due to Supply Chain Disruptions, A Major MDI/TDI Facility in the Middle East has Suddenly Shut Down!
-
From the Brink to the Bend: Bayer’s Q3 2025 Shows Dramatic Loss Reduction—but Crop Science Still Bleeds
-
Henkel to Acquire Olaplex in $1.4 Billion Deal
-
Growing Pains, But the Roots Are Strong: Corteva Narrows Losses Amid Sales Surge in Q3 2025
-
From Modest Gains to Massive Profits: Nutrien’s Q3 2025 Marks a Stunning Agricultural Comeback
Recommend Reading
-
Yara’s Green Surge: Record Profits Fuelled by Precision, Not Just Prices
-
Advent Drops Its 2026 Purchase, and LANXESS’s €1.2 Billion Exit Plan Falls Through
-
Sinopec and CNAF to Implement Restructuring
-
Dawn Seizes Strategic Control of EPDM Supply Chain with Acquisition of Ningbo SK—A Bold Leap Toward Global Elasticity
-
BASF to Sell Optical Brighteners Business to Catexel
-
Japan Tightens the Rules—Then Loosens Them: A Surprising Shift in Food Additive Policy
-
The End of Hype: Europe’s Bio-stimulant Industry Faces a Science-First Reckoning by 2030
-
Geopolitical Risks Recede, Dealing a Heavy Blow to the Oil Market; Short-Term Easing Does Not Alter Supply Constraints
-
Acetic acid market trends are weak and consolidating
-
Ethyl Acetate Prices Slightly Rise Within a Narrow Range